BioCentury | Jun 18, 2015
Financial News

Cynvenio raises $25.5 million in series B

...a set of blood-based tests to analyze circulating tumor cells for cancer-associated genomic mutations, and ClearID Breast Cancer...
BioCentury | Jan 27, 2014
Company News

CollabRx, Cynvenio Biosystems sales and marketing update

...the option to receive results along with GVA-based reporting. In October, Cynvenio launched worldwide its ClearID Breast Cancer...
BioCentury | Dec 23, 2013
Company News

CollabRx, Cynvenio Biosystems deal

...reporting. The partners could not be reached for details. In October, Cynvenio launched worldwide its ClearID Breast Cancer...
Items per page:
1 - 3 of 3